Nippon Shinyaku Co Ltd
TSE:4516
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2 789
5 411
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Nippon Shinyaku Co Ltd
Operating Income
Nippon Shinyaku Co Ltd
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
N
|
Nippon Shinyaku Co Ltd
TSE:4516
|
Operating Income
¥30.3B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
5%
|
CAGR 10-Years
16%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Operating Income
¥541.9B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
18%
|
CAGR 10-Years
16%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Operating Income
¥303.4B
|
CAGR 3-Years
50%
|
CAGR 5-Years
22%
|
CAGR 10-Years
10%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Operating Income
¥400.1B
|
CAGR 3-Years
30%
|
CAGR 5-Years
26%
|
CAGR 10-Years
6%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Operating Income
¥540.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
24%
|
CAGR 10-Years
21%
|
|
|
Astellas Pharma Inc
TSE:4503
|
Operating Income
¥130.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-1%
|
|
Nippon Shinyaku Co Ltd
Glance View
Nippon Shinyaku Co., Ltd. engages in the manufacture and sale of pharmaceuticals and foodstuffs. The company is headquartered in Kyoto, Kyoto-Fu and currently employs 2,059 full-time employees. The firm operates in two business segments. The Pharmaceutical segment is involved in the manufacture and sale of urinary system therapeutic agents, blood cancer therapeutic agents, pain, inflammation and allergic therapeutic agents, digestive system therapeutic agents, cardiovascular systems and metabolic therapeutic agents. The Functional Foodstuff segment involves in the manufacture and sale of health food materials, quality stability preservatives, protein preparation, spice and seasoning products. The firm is also involved in the business support business, non-life insurance agency business, as well as the provision of real estate leasing services.
See Also
What is Nippon Shinyaku Co Ltd's Operating Income?
Operating Income
30.3B
JPY
Based on the financial report for Sep 30, 2024, Nippon Shinyaku Co Ltd's Operating Income amounts to 30.3B JPY.
What is Nippon Shinyaku Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
16%
Over the last year, the Operating Income growth was -5%. The average annual Operating Income growth rates for Nippon Shinyaku Co Ltd have been -20% over the past three years , 5% over the past five years , and 16% over the past ten years .
You don't have any saved screeners yet
